Atlas Trials

Effect Aflibercept on Ocular Perfusion

Clinical trial NCT03804099 · COMPLETED

Trial details

NCT number
NCT03804099
Sponsor
Augenabteilung Allgemeines Krankenhaus Linz
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Macular DegenerationAnti Vascular Endothelial Growth Factor
Start date
2017-03-01
Primary completion
2018-03-20
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.